期刊
BIOCONJUGATE CHEMISTRY
卷 32, 期 3, 页码 448-465出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.1c00014
关键词
-
类别
资金
- National Institute of Pharmaceutical Education and Research (NIPER)-Ahmedabad
- SERB
- SERB-India
Peptides and chitosan are important biomolecules with potential for a wide range of biomedical applications. Hybridizing peptides and chitosan into new biomaterials can enhance their biosignaling properties and cell adhesion properties for use in drug delivery, tissue engineering, and other fields.
Peptides are signaling epitopes that control many vital biological events. Increased specificity, synthetic feasibility with concomitant lack of toxicity, and immunogenicity make this emerging class of biomolecules suitable for different applications including therapeutics, diagnostics, and biomedical engineering. Further, chitosan, a naturally occurring linear polymer composed of D-glucosamine and N-acetyl-D-glucosamine units, possesses anti-microbial, muco-adhesive, and hemostatic properties along with excellent biocompatibility. As a result, chitosan finds application in drug/gene delivery, tissue engineering, and bioimaging. Despite these applications, chitosan demonstrates limited cell adhesion and lacks biosignaling. Therefore, peptide-chitosan hybrids have emerged as a new class of biomaterial with improved biosignaling properties and cell adhesion properties. As a result, recent studies encompass increased application of peptide-chitosan hybrids as composites or conjugates in drug delivery, cell therapy, and tissue engineering and as anti-microbial material. This review discusses the recent investigations involving chitosan-peptide materials and uncovers various aspects of these interesting hybrid materials for biomedical applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据